Early trials demonstrate that Retatrutide – a dual activator of incretin and GIP receptors – offers a substantial improvement in weight loss programs . Unlike existing therapies, this dual-action compound seems to affect hunger and energy burn by means of separate mechanisms . While more investigation is essential, current results raise hope f… Read More